Azienda Sociosanitaria Ligure N 4 Sistema Sanitario Regione Liguria

The research at Azienda Sociosanitaria Ligure N 4 Sistema Sanitario Regione Liguria focuses on closely linked cardiovascular and metabolic conditions, especially the interaction between kidney health, blood pressure, and heart risk. These studies aim to improve treatment effectiveness and better protect patients with long-term chronic disease.

• Chronic kidney disease with hypertension
• Chronic kidney disease in type 2 diabetes mellitus
• Prevention of heart failure

The trials are evaluating whether new treatment combinations can slow kidney decline, reduce signs of kidney damage, and lower the risk of heart failure or cardiovascular death.

This research area centers on chronic kidney disease and high blood pressure, with a strong emphasis on finding better ways to preserve kidney function over time. The studies are designed to test whether combining therapies can offer more benefit than standard treatment alone.

• CKD progression and eGFR change
• Blood pressure-related kidney protection
• Treatment effectiveness and safety

At this site in Chiavari, investigators are examining approaches that may help slow disease worsening and support better long-term outcomes for people living with kidney and hypertension-related illness.

Another major focus is type 2 diabetes with chronic kidney disease, where the goal is to improve kidney protection while also addressing broader cardiovascular risk. These trials explore whether combination treatments can provide stronger control of disease markers than individual therapies.

• Reduction of urinary albumin
• Kidney disease in diabetes
• Lowering risk of heart failure events

The work reflects a practical effort to test new therapy combinations that may better manage both metabolic and heart-related complications in patients with complex chronic disease.